CIK 0001062822
- Non-accelerated filer
- Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760474169
- Phone
- +1 281-863-3000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- 4 Shares withheld for taxes SVP, Regulatory & QA gave up 24,353 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Medical Officer gave up 31,265 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, General Counsel & Secr. gave up 25,604 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 61,371 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 90,000 shares at $1.05 ($94,797)
- 4 Open-market buy Director bought 200,000 shares at $1.01 ($201,520)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $1.01 ($10,100)
- 4 Open-market buy Director bought 1,000,000 shares at an average $1.10 ($1,103,957)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President and CFO bought 10,000 shares at $1.38 ($13,800)
Page 6 of 34 · 673 filings